Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Meiji Seika discloses new neuroprotective substance isolated from fungus

Nov. 4, 1998

Novel isoquinoline anticonvulsants in development at SB

Nov. 4, 1998

Entropin concentrates its efforts on bringing Esterom to market

Nov. 4, 1998

Monoamine reuptake inhibitors especially useful for Parkinson's disease

Nov. 3, 1998

Positive CPMP opinion issued for Betaseron in new indication

Nov. 2, 1998

Licensing opportunity from the NIH: method of protecting neural cells from apoptosis

Nov. 2, 1998

Tacrolimus may represent novel neurotrophic strategy for neurodegenerative disorders

Oct. 30, 1998

Intravenous N-0923 associated with rapid onset and short-lasting antiparkinsonian effects

Oct. 30, 1998

Cytogen and Berlex enter into copromotion agreement for Quadramet

Oct. 30, 1998

Neuroprotective indolomorphinane derivatives under development at Toray

Oct. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...